Skip to main content
SKINBIOTHERAPEUTICS PLC logo

SKINBIOTHERAPEUTICS PLC — Investor Relations & Filings

Ticker · SBTX ISIN · GB00BF33H870 LEI · 213800YMQOCB23FX6I06 IL Manufacturing
Open in API
Filings indexed 302 across all filing types
Latest filing 2026-05-12 Major Shareholding Noti…
Country GB United Kingdom
Listing IL SBTX

About SKINBIOTHERAPEUTICS PLC

https://www.skinbiotherapeutics.com/

SkinBioTherapeutics PLC is a life science company focused on advancing skin health by harnessing the human microbiome. Its proprietary SkinBiotix® platform technology utilizes probiotic lysates to protect, manage, and restore skin. The company develops and commercializes products across several healthcare sectors, including cosmetics, food supplements, medical devices, and pharmaceuticals. Key offerings include AxisBiotix, a probiotic food supplement designed to address psoriasis symptoms, and the Dermatonics line of specialized foot care products. Through its acquisition of Bio-Tech Solutions, the company also provides formulation, manufacturing, and packaging services for healthcare, personal care, and hygiene products.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 91% confidence The document is a UK RNS TR-1 notification of major holdings form (Standard Form for Notification of Major Holdings), which reports the crossing of a shareholding threshold (26.971%) by named parties. This clearly fits the Major Shareholding Notification category.
2026-05-12 English
Holding(s) in Company
Regulatory Filings
2026-05-05 English
Update on the FRP Investigation
Regulatory Filings Classification · 72% confidence The document is a short RNS announcement providing an update on an internal forensic investigation by FRP Advisory. It does not contain financial statements or detailed results, nor is it announcing dividend, board changes, earnings, or a specific regulatory filing form. It is a general regulatory announcement via the London Stock Exchange’s RNS service. This falls under the fallback category for miscellaneous regulatory filings.
2026-04-29 English
Holding(s) in Company
Major Shareholding Notification Classification · 92% confidence The document is an RNS TR-1 notification of major holdings, showing the crossing of a shareholding threshold and detailing voting rights percentages as required under DTR5. This matches the definition of a Major Shareholding Notification (MRQ).
2026-04-01 English
Statement re. Suspension
Regulatory Filings Classification · 85% confidence The document is an RNS announcement (RNS Number: 9163Y) posted via the National Storage Mechanism/London Stock Exchange. It announces the suspension of trading due to delayed interim results, but does not itself contain the interim report or financial data. It fits the fallback category for general regulatory announcements (Regulatory Filings).
2026-04-01 English
Update On Board Investigation and Interims Date
Regulatory Filings Classification · 95% confidence The document is an RNS (Regulatory News Service) announcement from SkinBioTherapeutics plc. It informs shareholders about a delay in the publication of interim results due to an ongoing board investigation and provides notice of an expected suspension of trading. While it mentions interim results, it is not the report itself, but rather a regulatory update regarding the status of the company's reporting obligations and trading status. Therefore, it falls under the 'Regulatory Filings' category as it is a general corporate announcement regarding regulatory compliance and market status.
2026-03-20 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.